Tags:BiopharmaDevelopmentPlatformProductTechnology
NuCana is an oncology focused Biopharma company dedicated to the development and commercialization of new medicines to treat patients with cancer. The ProTide Technology Platform has the potential to transform chemotherapy to targeted therapy. ProTides have been designed to target specific patient populations for whom existing chemotherapy is not likely to be effective. By overcoming the key resistance pathways, ProTides aim to significantly improve the efficacy, broaden the clinical utility, and improve the safety profile of many established anticancer agents.
Location: United Kingdom, Edinburgh
Total raised: $57M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
11.04.2014Series B$57M--

Mentions in press and media 5

DateTitleDescriptionCategoryAuthorSource
24.05.2021NUCANA PLC...NuCana plc Notice of Annual G...--marketscre...
24.05.2021NUCANA PLC...NuCana plc Notice of Annual G...--marketscre...
13.09.2020Акции, ста...Активы шести университетских ф...Финансы...Olga Bakhl...vc.ru/fina...
11.04.2014NuCana Com...NuCana, an Edinburgh, UK-based...funding S...-finsmes.co...
29.11.2011NuCana Bio...NuCana BioMed, an Edinburgh UK...funding U...-finsmes.co...